Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
REGENXBIO Inc. shareholders approved Advisory vote to approve named executive officer compensation at the 2023-06-02 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-06-02
Exact text from the filing
Proposal 3 : By the following vote, the stockholders approved, on an advisory basis,the compensation of the Company’s named executive officers, as disclosed in the Proxy Statement: Votes For Votes Against Votes Abstaining Broker Non-Votes 36,733,345 1,131,884 111,321 1,965,878
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
REGENXBIO Inc. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm at the 2023-06-02 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-06-02
Exact text from the filing
Proposal 2 : By the following vote, the stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023: Votes For Votes Against Votes Abstaining Broker Non-Votes 39,799,734 50,694 92,000 0
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
REGENXBIO Inc. shareholders approved Election of three Class II directors at the 2023-06-02 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-06-02
Exact text from the filing
Proposal 1 : By the following vote, the following three persons were elected to serve as Class II directors until the Company’s 2026 annual meeting of stockholders: Nominee Votes For Votes Withheld Broker Non-Votes Jean Bennett, M.D., Ph.D. 30,318,877 7,665,786 1,965,878 A.N. “Jerry” Karabelas, Ph.D. 35,490,395 2,494,268 1,965,878 Daniel Tassé 35,984,653 2,000,010 1,965,878
View on SEC.gov